Replies to post #163220 on Biotech Values

[DewDiligence]

BMY/PFE’s own PR on the stellar Eliquis results in VTE treatment:

http://finance.yahoo.com/news/eliquis-apixaban-demonstrated-comparable-efficacy-194800289.html

[DewDiligence]

FDA accepts Eliquis nNDA for primary VTE prevention following hip/knee surgery; PDUFA date is 3/15/14:

http://finance.yahoo.com/news/fda-accepts-eliquis-apixaban-supplemental-113000798.html

Note: The sNDA in primary VTE prevention is separate from the sNDA in VTE treatment and secondary prevention, which is slated for submission to the FDA during the current quarter (#msg-89518539).